- Title
-
Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer
- Authors
- Murali Shankar, N., Ortiz-Montero, P., Kurzyukova, A., Rackwitz, W., Künzel, S.R., Wels, W.S., Tonn, T., Knopf, F., Eitler, J.
- Source
- Full text @ Front Immunol
PD-L1.CAR NK-92 cells are highly cytotoxic against PD-L1+ targets |
Labeled cancer and NK cells retain |
Kinetics of PD-L1.CAR NK-92 cytotoxicity in zebrafish |
CAR NK-92 cells specific for PD-L1 or ErbB2 show high efficacy against resistant breast cancer cells in a zebrafish xenograft model. |
Time-lapse imaging of CAR-NK cell interaction with cancer cells and cytotoxicity in the zebrafish tail. MDA-MB-231 GFP cells and 2 hours later PD-L1.CAR NK-92 cells (PKH26-labeled) were injected into the DoC. One hour after injection, confocal microcopy images were taken in the tail region. |
CAR-NK cells migrate to cancer cells within the vasculature. MDA-MB-231 GFP cells and PKH26-labeled PD-L1.CAR NK-92 cells were injected into transgenic Tg( |